Search
Master Class
Enhance your skills and expand your network with advanced online hematology training based on specially crafted clinical cases.
Read moreApply to be a Master Class mentor
Applications closed on July 15, 2024. There are two types of Master Class mentor: junior mentor and senior mentor. Before you apply, make sure you've read and understood the relevant eligibility criteria.
Read moreApply to be a Master Class mentee
Applications closed on July 15, 2024
EligibilityTo apply to be a menteee, you must be one of the following:
A hematologist
Receiving hematology training
Seeing hematology patients
You must also be an EHA member.
Abstract & Clinical Case Submission and Travel Grant
Submit your abstract here
Abstract and clinical case procedurePlease note that the submission of an abstract constitutes a formal commitment by the presenting author to present the abstract (if accepted) orally or as a poster in the session at the time…
Presidential Speakers
Promising crucial developments in the field of hematology, the speakers and presentation topics of the EHA2025 Presidential Session speakers are now available. Friday, June 13, 2025 - Presidential Session I
Immunotherapy (TCR related)
Prof.
Abstract Presentation Information
Thank you for submitting your abstract to the EHA Research Conference 2025, to be held on March 17-20, 2025 in Málaga, Spain.
Read moreMembership
Boost your career, fast-track your development, and make new connections by joining a pioneering European hematology organization with global reach.
Read moreResearch training documents for scholars
CBTH documentsCBTH Non-disclosure Agreement
CRTH documentsCRTH Conditions of Acceptance and Participation
CRTH Non-disclosure Agreement
TRTH documentsTRTH Non-disclosure Agreement
Selected EMA news
November 2024New medicines recommended for approval
Eltrombopag Viatris (eltrombopag) – generic
Treatment of primary immune thrombocytopenia and thrombocytopenia associated with chronic hepatitis C (disease in which patients have low levels of blood platelets)
Alhemo (concizumab)
Prevention of bleeding in patients with hemophilia A…